Tech Company Financing Transactions
BrainTale Funding Round
BrainTale secured a $4.9 million venture capital round on 6/20/2023. Backers included Capital Grand Est and MACSF.
Transaction Overview
Company Name
Announced On
6/20/2023
Transaction Type
Venture Equity
Amount
$4,890,000
Round
Undisclosed
Investors
Capital Grand Est (Lead Investor)
MACSF (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate its expansion in Europe and the United States.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
11 rue de l'académie
Strasbourg, 67000
USA
Strasbourg, 67000
USA
Phone
Undisclosed
Website
Email Address
Overview
BrainTale is an innovative company opening a new era in medicine. We aim at providing physicians with clinically validated diagnostic, monitoring and prognostic solutions for the management of brain injured patients through sensitive and reliable measurements of white-matter microstructure alterations. Building on more than 15 years of clinical development, BrainTale's products are developed collaboratively to address medical need and fulfil expectations of healthcare professionals and patients alike.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Julie Rachline
Chief Technical Officer
Jean Martini
President
Vincent Perlbarg
Browse more venture capital transactions:
Prev: 6/20/2023: TransBnk venture capital transaction
Next: 6/20/2023: Rose Rocket venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs